Targeting lysosomal quality control as a therapeutic strategy against aging and diseases
Medicinal Research Reviews · 2024-11 · 44 (6) · 2472-2509
DOI: 10.1002/med.22047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicinal Research Reviews, online erschienen am 06.05.2024. Verfasst von Yuchen He und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Lysosomes, Aging. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Hunan Province, Hunan Provincial Health Commission, Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University.
Abstract (Originalsprache)
Previously, lysosomes were primarily referred to as the digestive organelles and recycling centers within cells. Recent discoveries have expanded the lysosomal functional scope and revealed their critical roles in nutrient sensing, epigenetic regulation, plasma membrane repair, lipid transport, ion homeostasis, and cellular stress response. Lysosomal dysfunction is also found to be associated with aging and several diseases. Therefore, function of macroautophagy, a lysosome‐dependent intracellular degradation system, has been identified as one of the updated twelve hallmarks of aging. In this review, we begin by introducing the concept of lysosomal quality control (LQC), which is a cellular machinery that maintains the number, morphology, and function of lysosomes through different processes such as lysosomal biogenesis, reformation, fission, fusion, turnover, lysophagy, exocytosis, and membrane permeabilization and repair. Next, we summarize the results from studies reporting the association between LQC dysregulation and aging/various disorders. Subsequently, we explore the emerging therapeutic strategies that target distinct aspects of LQC for treating diseases and combatting aging. Lastly, we underscore the existing knowledge gap and propose potential avenues for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, China.
- Center for Neuromusculoskeletal Restorative Medicine, Hong Kong Science Park, Shatin, NT, Hong Kong SAR, China.
ORCID-Profile: Yuchen He
Förderung
- Natural Science Foundation of Hunan Province
- Hunan Provincial Health Commission
- Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University
Zitieren
APA
He, Y., Fan, Y., Ahmadpoor, X., Wang, Y., Li, Z. A., Zhu, W., & Lin, H. (2024). Targeting lysosomal quality control as a therapeutic strategy against aging and diseases. Medicinal Research Reviews, 44(6), 2472-2509. https://doi.org/10.1002/med.22047
Vancouver
He Y, Fan Y, Ahmadpoor X, Wang Y, Li ZA, Zhu W, et al. Targeting lysosomal quality control as a therapeutic strategy against aging and diseases. Medicinal Research Reviews. 2024;44(6):2472-2509. doi:10.1002/med.22047
BibTeX
@article{He2024,
author = {He, Yuchen and Fan, Yishu and Ahmadpoor, Xenab and Wang, Yumin and Li, Zhong Alan and Zhu, Weihong and Lin, Hang},
title = {Targeting lysosomal quality control as a therapeutic strategy against aging and diseases},
journal = {Medicinal Research Reviews},
year = {2024},
volume = {44},
number = {6},
pages = {2472--2509},
doi = {10.1002/med.22047}
}
EUVIMED